• This record comes from PubMed

Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema

. 2009 Oct ; 247 (10) : 1307-14. [epub] 20090509

Language English Country Germany Media print-electronic

Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Histopathologic and morphometric analysis of the internal limiting membrane (ILM) in diabetic eyes was performed. The thickness of the ILM was correlated with the level of glycosylated hemoglobin (HbA(1C)) and other clinical factors. METHODS: The prospective study involved 56 eyes of 52 diabetic patients with a mean age of 63 +/- 7.6 years. Vitrectomy with trypan blue-assisted ILM peeling was performed in the standard way. The mean follow-up period was 8.7 months (range 3-19 months). The ILM was fixed immediately after peeling in 2.5% glutaraldehyde and submitted for electron microscopic evaluation. The ILM was photographed at standard magnification (x5,000) with the scale of 1 microm in the shot. RESULTS: Morphometric analysis demonstrated a significant thickening of the ILM in all eyes, with a mean thickness of the ILM of 3.61 +/- 1.22 microm. It was found that a higher thickness of the ILM is related to elevated HbA(1C) in both types of diabetes mellitus (DM) (p = 0.040). We also found significant dependence of ILM thickness in relation to duration of DM by comparison of men and women (p = 0.026), and a significant correlation between ILM thickness and the age of diabetic patients related to their gender (p = 0.029). CONCLUSIONS: We confirmed increased thickness of the surgically peeled ILM and statistically significant correlations to elevated HbA(1C) in both types of DM, and to further clinical characteristics of case series. Morphometric and histopathologic analyses of the ILM contribute to more objective evaluation of the ultrastructure of the vitreomacular interface.

See more in PubMed

Retina. 2005 Jun;25(4):454-61 PubMed

Retina. 2008 Mar;28(3):420-6 PubMed

Graefes Arch Clin Exp Ophthalmol. 2004 May;242(5):402-8 PubMed

Retina. 2005 Sep;25(6):742-5 PubMed

Am J Ophthalmol. 1999 Sep;128(3):317-23 PubMed

Ophthalmology. 2004 Feb;111(2):226-30 PubMed

Retina. 2005 Apr-May;25(3):311-6 PubMed

Retina. 2004 Oct;24(5):721-7 PubMed

Graefes Arch Clin Exp Ophthalmol. 2004 Oct;242(10):845-52 PubMed

Retina. 2008 Mar;28(3):410-9 PubMed

Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):630-7 PubMed

BMJ. 1998 Sep 12;317(7160):703-13 PubMed

Retina. 2006 Jan;26(1):5-13 PubMed

Ophthalmic Res. 2003 Jul-Aug;35(4):192-8 PubMed

N Engl J Med. 1993 Sep 30;329(14):977-86 PubMed

Invest Ophthalmol. 1972 Oct;11(10):801-8 PubMed

Arch Ophthalmol. 1991 Jul;109(7):966-71 PubMed

Br J Ophthalmol. 1999 Jan;83(1):12-4 PubMed

Graefes Arch Clin Exp Ophthalmol. 2002 Jun;240(6):423-9 PubMed

Cesk Slov Oftalmol. 2002 Jul;58(4):224-32 PubMed

Am J Ophthalmol. 2005 Dec;140(6):1123-5 PubMed

Am J Ophthalmol. 1996 Aug;122(2):258-60 PubMed

Ophthalmology. 1992 May;99(5):753-9 PubMed

Eur J Ophthalmol. 2004 Mar-Apr;14(2):137-43 PubMed

Retina. 2000;20(5):554-5 PubMed

Retina. 2000;20(2):126-33 PubMed

Am J Ophthalmol. 2005 Apr;139(4):620-3 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...